GC Labs
GC Labs is South Korea's oldest commercial clinical reference laboratory, providing approximately 5,000 diagnostic test items to hospitals, clinics, and pharmaceutical clients through automated, accredited testing centers in Yongin, Yeongnam, and Honam.
- Company typePrivate
- Founded1982
- HeadquartersYongsin, South Korea
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What GC Labs does
GC Labs (의료법인 녹십자의료재단, Medical Corporation Green Cross Medical Foundation) is South Korea's oldest commercial clinical reference laboratory, founded in 1982 as Green Cross Bio Science Lab and rebranded to its current identity in 2012. The organization operates as a medical corporation (의료법인) within the GC Group (Green Cross Corporation / GC Biopharma) family of companies, with headquarters in Yongin, Gyeonggi-do, and serves hospitals, clinics, and pharmaceutical companies nationwide through two main divisions — a Medicine Center and a Pathology Center — plus regional facilities in the Yeongnam (Yangsan) and Honam (Gwangju) areas that were completed in September 2024.
The company's technical platform spans Total Laboratory Automation (TLA) for pre- to post-analytical workflows, the first domestic WASPLab Microbiology Automation deployment, tandem mass spectrometry (including proprietary newborn screening methods), molecular pathology platforms (PCR, sequencing, FISH, SISH), immunohistochemistry, and a digital pathology system under construction. It holds a broad accreditation stack — CAP, ISO 15189, NGSP Level 1 for HbA1c, CDC VDSCP and HoSt certifications, ISO 9001/14001, G-EQUAS, and ISBER — and offers approximately 5,000 test items spanning clinical chemistry, hematology, immunology, microbiology, molecular genetics, pathology, allergy, toxicology, and therapeutic drug monitoring, processing roughly 53,000 specimens per day domestically.
GC Labs monetizes through contract-based diagnostic testing referrals from medical institutions (general clinical tests, specialized diagnostics, and anatomical pathology), supplemented by pharmaceutical central laboratory services for clinical trials, IVD clinical performance testing (the first domestic designated institution for this since 2020), and special health examination services. Marketing is anchored in academic channels — IFCC WorldLab, LMCE, Korean Society for Laboratory Medicine participation, peer-reviewed publications — and distribution flows through a direct enterprise sales motion covering a nationwide network of specimen collection centers and dedicated logistics for pickup and delivery. As a founding member of the Global Diagnostics Network, the foundation also participates in cross-border specimen work spanning approximately 75 countries.
GC Labs firmographics
Firmographics- Name
- GC Labs
- Legal name
- 의료법인 녹십자의료재단
- Website
- https://gclabs.co.kr
- Company type
- Private
- Founded year
- 1982
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- GC Labs is South Korea's oldest commercial clinical reference laboratory, providing approximately 5,000 diagnostic test items to hospitals, clinics, and pharmaceutical clients through automated, accredited testing centers in Yongin, Yeongnam, and Honam.
- Ownership category
- akta.pro rank
GC Labs industry classification
Industry- Product category
- Clinical Laboratory Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reference & Esoteric Testing Laboratories (HLAFAMAJ)
Keywords
Where GC Labs is headquartered
LocationHeadquarters
- HQ city
- Yongsin
- HQ country
- South Korea
- HQ region
- Asia
Offices3 records
Markets served
GC Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Laboratory Testing Services: Provides diagnostic testing services to medical institutions, hospitals, and clinics on a contract basis. Services include general tests, specialized tests, and pathology examinations.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
GC Labs product offering
Product offeringCore offering
GC Labs operates as a comprehensive clinical laboratory testing organization providing approximately 5,000 diagnostic test items through its Medicine Center, Pathology Center, and regional centers. Services span clinical chemistry, hematology, immunology, microbiology, molecular genetics, and anatomical pathology, supported by Total Laboratory Automation, tandem mass spectrometry, and molecular diagnostics. The organization also operates the Epi-wave infectious disease epidemiology monitoring platform for public health surveillance.
Product overview
GC Labs operates as a comprehensive clinical laboratory testing organization offering approximately 5,000 clinical test items through its main Medicine Center (진검센터) and Pathology Center (병리센터), supplemented by regional centers in Yeongnam and Honam regions. The company's core offerings include specialized diagnostic testing services across clinical chemistry, hematology, immunology, microbiology, molecular genetics, and anatomical pathology. Additionally, GC Labs provides the Epi-wave infectious disease epidemiology monitoring platform, which offers public-facing dashboards for respiratory infections, influenza surveillance, and gastrointestinal infections. The organization also conducts clinical research testing and provides consulting services for international laboratory setup and operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Testing Services Comprehensive clinical laboratory testing services including approximately 5,000 test items covering clinical chemistry, hematology, immunology, microbiology, molecular genetics, and specialized testing areas such as allergy, toxicology, and drug monitoring. Services are provided on a referral basis to hospitals, clinics, and medical institutions across South Korea.
- Anatomic Pathology Services Anatomic pathology reference testing services including histopathology, immunohistochemistry, molecular pathology (PCR, sequencing, FISH, SISH) for cancer diagnosis and drug sensitivity prediction. Services are provided through a dedicated Pathology Center with digital pathology system capabilities.
- Epi-wave Infectious Disease Epidemiology Platform Digital platform providing public-facing dashboards for monitoring respiratory infections, influenza surveillance, and gastrointestinal infections. Enables disease pattern detection and outbreak monitoring for public health agencies and medical institutions.
- Clinical Research Testing Services Central laboratory services for clinical trials, providing standardized, high-quality testing for pharmaceutical companies and research institutions conducting clinical studies. Includes companion diagnostics central lab capabilities through partnerships such as with QIAGEN.
Quantifiable outcome
- Processing 53,000 specimens daily
- +2 more outcomes
Companies that use GC Labs
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
GC Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature5 records
GC Labs partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, major and minor.
- InpecocoreMOU signed for comprehensive strategic cooperation including pathology laboratory automation equipment introduction.
- QuantMatrixmajorJoint infectious disease research partnership.
- KOFIH (Korea International Health Foundation)majorOperating KOFIH's Lee Jong-wook Fellowship infectious disease response expert training program for developing countries.
- QIAGEN Manchester LimitedmajorCompanion diagnostics central lab program (DAY-ONE LAB READINESS) partnership.
- KNCV Tuberculosis FoundationmajorPartnership for tuberculosis elimination activities.
- MBD Co.minorMOU for anticancer drug sensitivity diagnostic testing business using organoid solutions.
- Ewha Womans UniversityminorIndustry-academia collaboration agreement for talent development.
- Global Diagnostics Network (GDN)coreGC Labs is a founding member of the Global Diagnostics Network, a strategic alliance of major diagnostic laboratories worldwide including Quest Diagnostics (USA), Dasa (Brazil), Life Labs (Canada), Synlab (Germany), Al Borg (Saudi Arabia), and others covering 75 countries with access to 300 million patients annually.
- Seoul National University HospitalminorJoint research MOU for diagnostic development.
- Dankook University HospitalminorClinical trial joint research MOU.
Scale indicators6 records
Recent moves12 records
Expansion highlights6 records
GC Labs competitors and assessment
Company assessmentDirect peers
- LifeLabs: Canadian clinical laboratory and GDN founding member. Directly comparable as a hospital-facing reference testing provider operating within the same global network alliance.
- Al Borg Medical Laboratories: Middle East–headquartered clinical reference lab and GDN founding member. Comparable as a hospital-facing diagnostics provider with similar broad test menus and GDN integration.
- Seoul Clinical Laboratories (SCL / GC Labs affiliate GCCL): Korean clinical reference laboratory operating within the GC Group family. Direct competitor in Korean hospital reference testing and clinical trial central lab services, with overlapping customer base and accreditations.
- Quest Diagnostics: US-headquartered clinical reference laboratory and GDN founding member. Directly comparable as a global clinical lab providing routine and esoteric testing to hospitals and physicians; shares the GDN platform with GC Labs.
- Synlab: European clinical reference laboratory and GDN founding member. Direct comparable as a multi-country reference lab operator serving hospitals with broad test menus and central lab services for clinical trials.
- Dasa: Brazilian diagnostics operator and GDN founding member. Comparable as a regional clinical reference lab providing routine and specialty testing to hospitals, with GDN cross-border referral access.
Broad incumbents
- Laboratory Corporation of America (Labcorp): US-headquartered global clinical laboratory incumbent. Comparable as a broad-based reference testing provider with deep specialty diagnostics, central lab, and clinical trial services.
- BML: Japan-based clinical reference laboratory. Comparable as a large Asian hospital-facing reference testing provider with broad test menu and central lab capabilities.
- SRL (SRL Medisearch): Japan-based major clinical reference laboratory. Comparable as a large Asian hospital-facing reference lab with broad specialty testing, including central lab services for clinical trials.
Regional players
- Eone Diagnomics Genome Center: Korean molecular diagnostics and genome analysis provider. Comparable as a Korean specialty diagnostics player competing in molecular and genetic testing adjacencies to GC Labs' molecular pathology offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
GC Labs social profiles
Digital presenceGC Labs compliance and trust
Trust signalCompliance8 records
GC Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
GC Labs leadership team
Management profileNumber of profiles
Profiles2 records
GC Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GC Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GC Labs
What does GC Labs do?
GC Labs operates as a comprehensive clinical laboratory testing organization providing approximately 5,000 diagnostic test items through its Medicine Center, Pathology Center, and regional centers. Services span clinical chemistry, hematology, immunology, microbiology, molecular genetics, and anatomical pathology, supported by Total Laboratory Automation, tandem mass spectrometry, and molecular diagnostics. The organization also operates the Epi-wave infectious disease epidemiology monitoring platform for public health surveillance.
Is GC Labs a public or private company?
GC Labs is a private company. It is classified as corporate owned and is currently operating.
When was GC Labs founded?
GC Labs was founded in 1982. It employs 501 to 1,000 people.
Where is GC Labs based?
GC Labs is headquartered in Yongsin, South Korea, in the Asia region.
How does GC Labs make money?
One revenue line is on record: clinical Laboratory Testing Services.
Who are GC Labs's main competitors?
Direct peers on record are LifeLabs, Al Borg Medical Laboratories, Seoul Clinical Laboratories (SCL / GC Labs affiliate GCCL), Quest Diagnostics, Synlab and Dasa. Broad incumbents are Laboratory Corporation of America (Labcorp), BML and SRL (SRL Medisearch). Eone Diagnomics Genome Center is listed as a regional player.
Does GC Labs have an API?
No public API is recorded for GC Labs.
What industry is GC Labs in?
GC Labs's product category is Clinical Laboratory Testing Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.